Post-earnings recap
Reported
Thu, Feb 2, 2017
EPS actual
$1.21
EPS est.
$0.51
EPS surprise
+137.25%
1-day move
-0.72%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
AstraZeneca reported a strong EPS that significantly exceeded expectations, indicating positive performance in its operations. However, the stock reacted negatively, declining by 0.72%. This could suggest that investors were looking for more comprehensive revenue details or future guidance, which were not provided.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.21 | N/A | +137.25% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.